Top News
Latest News
RESEARCH
10 Apr 2026
Standard mRNA Had a Good Run. Then Came This.REGULATORY
9 Apr 2026
RNA Medicine Reaches a Disease No Drug Has Ever TouchedINNOVATION
8 Apr 2026
A Self-Driving Lab Just Rewrote the Rules of mRNA DeliveryPARTNERSHIPS
7 Apr 2026
Sahin and Türeci Are Back at the Drawing Board
RNA Gets a $2.4B Promotion at Eli Lilly
INVESTMENT
6 Apr 2026
Eli Lilly acquires Orna Therapeutics for up to $2.4B, bringing circular RNA and in vivo CAR-T into its US pipeline
RESEARCH
10 Apr 2026
Standard mRNA Had a Good Run. Then Came This.
Phase 3 data shows Arcturus' sa-mRNA vaccine produces more durable, functionally superior antibody responses than conventional mRNA
REGULATORY
9 Apr 2026
RNA Medicine Reaches a Disease No Drug Has Ever Touched
Ionis wins Priority Review for zilganersen, targeting the first-ever treatment for a rare, fatal brain disease
INNOVATION
8 Apr 2026
A Self-Driving Lab Just Rewrote the Rules of mRNA Delivery
A self-driving AI platform has identified a novel lipid class that outperforms the delivery system at the core of Moderna's Covid-19 vacci...
PARTNERSHIPS
7 Apr 2026
Sahin and Türeci Are Back at the Drawing Board
BioNTech co-founders will leave by year-end to launch a new next-gen mRNA company, with BioNTech taking a minority stake
INVESTMENT
6 Apr 2026
RNA Gets a $2.4B Promotion at Eli Lilly
Eli Lilly acquires Orna Therapeutics for up to $2.4B, bringing circular RNA and in vivo CAR-T into its US pipeline
PARTNERSHIPS
31 Mar 2026
RNA Meets Cell Therapy, and Texas Is Holding the Handshake
Cellipont and Soter Bio launch an integrated US platform linking GMP RNA production to cell therapy manufacturing
SUBSCRIBE FOR UPDATES
By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.